Thomas Iftner

Leader/sub-project leader in joint projects from public funds

2008 – 2012 Speaker of the Integrated Research Training Group "Molecular Oncology" in SFB 773 "Therapy resistance of solid tumours and how to overcome it”

2006 – 2010 Deputy coordinator in the EU-funded research project INCA (The role of chronic infections in the development of cancer, Project no. LSHC-CT-2005-018704)

2002 – 2005 Sub-project leader in the EU-funded project “Viruses and Skin Cancer Risks” (VIRASKIN)

2001 – 2005 Speaker of the EU research programme “Development of Mathematical Models of Novel HPV-based Cervical Cancer Screening Protocols for Evaluation of the Projected Health and Cost Benefits” (HPVCCS), QLG4-CT-2000-01238)

2001 – 2005 Speaker of the Research Training Group 686-1 “Mechanisms of the development of solid tumours and experimental therapy concepts”

2001 – 2004 Speaker of the EU research programme “Cervical Cancer Public Education“(CCPED) QlG4-CT-2001-30142

Academic positions

2006-2017 Dean of Students and Founder of the Programme “Molecular Medicine” at the Medical Faculty of the University of Tübingen Medicine

2006-2019 Member of the Faculty Advisory Board of the Medical Faculty at the University of Tübingen

2010-2020 Vice Dean of the Medical Faculty at the University of Tübingen

Editorial Boards

Since 2016 Member of the Editorial Board “Tumor Virus Research” (formerly Papillomavirus Research)

Since 2010 Member of the Editorial Board “ American Journal of Cancer Research”

Other activities

Since 2022 Representative of the German Society for Virology e.V. for the preparation of the revised S3 guideline " Prevention of cervical carcinoma".

Since 2021 Member of the Committee on Scientific and Technological Cooperation (COMSTECH) of the Organization of Islamic Countries (OIC)

2020-2022 Member of the expert group "Aerosols" of the Ministry of Science, Research and the Arts Baden-Württemberg and advisor to the state government of Baden-Württemberg

Since 2019 Consultant for the establishment of the „National Institutes of Virology“ at the University of Karachi and the International Center for Chemical and Biological Sciences

since 2017 Chair of the Medical Faculty's Technology Transfer Task Force, Tuebingen

2016 Conference President, together with Elmar Joura, of EUROGIN 2016 in Salzburg, Austria “HPV 2016: From Science to Practice”

2015 – 2018 Representative of the German Society for Virology e.V. for the preparation of the S3 guideline "Prevention of cervical carcinoma".

2013 – 2020 Head of the Core Facility Management Board of the Faculty of Medicine,Tuebingen

2011 – 2020 Member of the Board of Directors „International Papillomavirus Society“ (www.ipvs.org)

2008 Publisher of the book „HPV und Zervixkarzinom – Diagnostik und Prophylaxe“ UNI-MED, Bremen

2007 Member of the WHO expert group for the preparation of the “IARC Monographs On The Evaluation Of Carcinogenic Risks To Humans” Vol.64 Human Papillomaviruses, in which the risk classification of the 13 high risk HPV types, which is still valid today, was developed and published

Since 2006 Chairman and initiator of the “Zervita”(www.zervita.de) project group which aims to inform the public about risk factors, prevention, early detection and treatment of cervical cancer

2005 Expert reviewer for the EMA for the validation of the HPV Vaccine Cervarix

2005 Member of the WHO expert group for the preparation of the "IARC Handbook of Cancer Prevention “Cervical Cancer Screening”

2003 – 2009 Member of the Board of Directors ECCA "European Cervical Cancer Association ", Brüssel (former Lyon)

2002 – 2005 Member of the Board of Directors ECCCE "European Consortium for Cervical Cancer Education", London